On Thursday, Sensata Technologies Holding N.V. (NYSE:ST)’s shares declined -0.38% to $49.66.
Sensata Technologies Holding N.V. (ST) declares results of its operations for the second quarter ended June 30, 2015.
Highlights of the Three and Six Months ended June 30, 2015
Net revenue for the second quarter 2015 was $770.4 million, an enhance of $194.6 million, or 33.8%, from $575.9 million for the second quarter 2014. Net income for the second quarter 2015 was $40.9 million, or $0.24 per diluted share. This compares to Net income for the second quarter 2014 of $63.9 million, or $0.37 per diluted share. Adjusted net income1 for the second quarter 2015 was $124.6 million which was 16.2% of Net revenue, or $0.73 per diluted share. This was an enhance of 16.6% contrast to Adjusted net income1 for the second quarter 2014 of $106.8 million which was 18.6% of Net revenue, or $0.62 per diluted share. Integration charges related to acquisitions were $4.2 million for the second quarter of 2015.
Sensata Technologies Holding N.V., through its auxiliaries, develops, manufactures, and sells sensors and controls. It operates in two segments, Sensors and Controls. The Sensors segment manufactures pressure, temperature, speed, position, and force sensors, in addition to electromechanical sensors. Its products are used in subsystems of automobiles, such as engine, air conditioning, and ride stabilization; heavy off-road vehicles; and systems that address safety and environmental concerns.
Sangamo Biosciences, Inc. (NASDAQ:SGMO)’s shares gained 7.12% to $8.27.
Sangamo BioSciences, Inc. (SGMO) stated its second quarter 2015 financial results and accomplishments.
For the second quarter ended June 30, 2015, Sangamo stated a merged net loss of $12.1 million, or $0.17 per share, contrast to a net loss of $7.0 million, or $0.10 per share, for the same period in 2014. As of June 30, 2015, the Company had cash, cash equivalents, marketable securities and interest receivable of $218.6 million.
Revenues for the second quarter of 2015 were $8.4 million, contrast to $10.4 million for the same period in 2014. Second quarter 2015 revenues were generated from the Company’s partnership agreements with Shire International GmbH (Shire), Biogen Inc. (Biogen), enabling technology agreements and research grants. The revenues recognized for the second quarter of 2015 comprised of $7.8 million in partnership agreements and $0.6 million in research grants, contrast to $9.7 million and $0.7 million, respectively, for the same period in 2014.
Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focused on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for various monogenic and infectious diseases with unmet medical needs. Its proprietary zinc finger DNA-binding protein (ZFP) technology enables precise and highly specific genome modification and gene regulation.
At the end of Thursday’s trade, Zimmer Biomet Holdings Inc (NYSE:ZBH)‘s shares surged 0.66% to $104.36.
Zimmer Biomet Holdings, Inc. (ZBH) stated financial results for the quarter ended June 30, 2015. The Company stated second quarter net sales of $1.17 billion, a decrease of 1.3% stated and an enhance of 5.7% constant currency contrast to the second quarter of 2014. Attained revenue from Biomet amounted to $60 million, a contribution of 5.0% of the constant currency growth rate. Standalone Zimmer recorded constant currency growth in the quarter of 0.7%. Stated net loss per share for the quarter was $(0.91) and adjusted earnings per share were $1.59, an enhance of 0.6% over the preceding year period.
Zimmer Biomet Holdings, Inc., together with its auxiliaries, designs, develops, manufactures, and markets orthopaedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific.
GameStop Corp. (NYSE:GME), ended its Thursday’s trading session with 1.05% gain, and closed at $46.10.
GameStop Ireland is launching Zing Pop Culture, the kings of cool that lead the way in offering every type of pop culture “loot” imaginable, from kid classics like Pokemon and Disney toys, to hard-core collectibles from Marvel, Star Wars and more.
GameStop Ireland has introduced the Zing Pop Culture range of products into its 50 stores across the country, in addition to launching a dedicated store within GameStop’s flagship store on Dublin’s Henry Street.
Zing Pop Culture, Henry Street, will officially open at 11:00 a.m. on Saturday 8th August and the first 40 customers in-store will receive a €25 voucher to spend towards whatever “loot” they like. Superhero celebrities will be on hand to entertain the crowd and customers will enjoy ‘Big Kid Canapés’ and juice boxes, while radio station Spin 103.8 spins some tunes from the greatest pop culture movies ever made.
GameStop Corp. operates as a multichannel video game retailer. It sells new and pre-owned video game hardware; physical and digital video game software; pre-owned and value video game products; video game accessories, such as controllers, gaming headsets, memory cards, and other add-ons for use with video game hardware and software; and digital products, counting downloadable content, network points cards, prepaid digital and online timecards, and digitally downloadable software.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.